SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001250853-13-000150
Filing Date
2013-12-13
Accepted
2013-12-13 12:43:18
Documents
1
Period of Report
2013-12-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3271
  Complete submission text file 0001250853-13-000150.txt   4658
Mailing Address 58 WEST PORTAL AVE., #105 SAN FRANCISCO CA 94127
Business Address 58 WEST PORTAL AVE., #105 SAN FRANCISCO CA 94127 415-596-1557
Kindred Biosciences, Inc. (Issuer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KINDRED BIOSCIENCES, INC. 1499 BAYSHORE HIGHWAY, SUITE 226 BURLINGAME CA 94010
Business Address
Schultz Kevin (Reporting) CIK: 0001593868 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36225 | Film No.: 131275625